Emd Serono Research & Development Institute, Inc.

This is the first human study of an experimental cancer drug called M3554. It aims to find a safe dose and check for early signs that the drug might help control advanced soft tissue sarcomas and glioblastoma brain tumors. The study will enroll about 52 adults whose cancer has pr…

This is the first human study of an experimental cancer drug called M7437, designed to target specific proteins found on cancer cells. The trial aims to find a safe dose and see if the drug shows early signs of effectiveness in people with advanced solid tumors that have stopped …

This study is testing an experimental drug called M9140 in people with advanced gastric, lung, or pancreatic cancer that has stopped responding to standard treatments. The trial aims to see if M9140 can shrink tumors and is safe for patients. It will enroll about 250 adults whose…

This is the first human study of an experimental drug called M9140 for people with advanced colorectal cancer that has progressed after standard treatments. Researchers will test different doses to find the safest amount and see if the drug shows early signs of helping control th…

This is the first study in people to test a new drug called M0324 for advanced solid tumors. The main goal is to find a safe dose and see how the body handles the drug. Researchers will test M0324 alone, with an immunotherapy drug, and with chemotherapy in about 77 participants.

This study is a registry that aims to collect information on how patients with a specific type of advanced lung cancer (NSCLC with a METex14 genetic change) are treated in real-world clinics and what their outcomes are. It will follow about 700 patients over time to understand tr…